QY Research: Global In Vitro Diagnosis (IVD) Products Market Size Will Reach 100 Billion by 2025

In Vitro Diagnosis (IVD), is also known as In Vitro Diagnostic. It refers to outside the human body, through the human body sample (blood, body fluids, tissues, etc.) to obtain clinical diagnostic information, and then determine the disease or body function of products and services. n vitro diagnostic products are mainly composed of diagnostic equipment (instruments) and diagnostic reagents.

Figure In Vitro Diagnosis (IVD) Segment Life Cycle Analysis

The main levels of In Vitro Diagnosis (IVD) are divided into Immunoassays, Molecular diagnostics involves, Point-of-care testing (POCT or bedside testing), and chemistry Diagnosis according to different diagnostic method

On the in vitro diagnostic products market share, POCT, microbes and the immune is more, POCT class is mainly due to the European and American developed countries because of diet structure and institutional reasons, fast blood glucose detection application in in vitro diagnostic market more, therefore occupy a larger proportion, microbe, immune, such as molecular ratio are also occupy a certain market.

Figure in Vitro Diagnostic Market Composition

Immunoassays usually refers to the system that measure and controls a patient’s physiological parameters and can be compared with a known set value to warn if there is an excess. They must continuously monitor the patient’s physiological parameters for 24 hours, detect the change trend, point out the imminent danger, provide the doctor with the basis for emergency treatment and treatment, and reduce the complications to the minimum to achieve the purpose of alleviating and eliminating the condition.

The major Immunoassays player in the market

• Abbott
• BD
• Roche
• Danaher
• Devon Medical Products
• EDP Biotech
• Hologic
• Luminex
• Meridian Life Science
• QIAGEN

Point-of-care testing (POCT or bedside testing) is defined as medical diagnostic testing at or near the point of care—that is, at the time and place of patient care.

The major Point-of-care testing equipment player in the market

• Siemens Healthcare
• Danaher
• Ascensia
• Bio-Rad Laboratories
• BioMerieux
• ARKRAY
• Nova Biomedical
• Trividia Health
• Quidel
• Accriva
• OraSure Technologies
• Helena Laboratories
• A. Menarini Diagnostics
• Abaxis (Zoetis)
• Wondfo Biotech
• Ortho Clinical Diagnostics

Molecular diagnostics involves gene sequencing, protein structure and other microscopic levels. DNA, RNA and protein are measured by molecular biology to determine the changes in the structure and expression level of genetic material in patients, so as to make diagnosis.

It accounts for a large share of molecular diagnostics cancer and COVID-19.

Request Sample Report@ 

https://www.qyresearch.com/sample-form/form/1640045/global-in-vitro-diagnosis-ivd-key-trends-and-opportunities-to-

The major Molecular diagnostics player in the market

• Abbott Laboratories
• Agilent Technologies
• BD
• Roche Diagnostics
• Siemens AG
• Thermo Fisher Scientific
• Biomerieux
• Danaher Corporation
• Diasorin
• Grifols
• Hologic
• Illumina
• Qiagen

At the same time, in vitro detection can be divided into in vitro diagnostic reagents and in vitro diagnostic instruments according to the product type, which are the same principle as above.

In Vitro Diagnosis (IVD) agents are divided into biochemical diagnostic reagents, immunodiagnostic reagents, molecular diagnostic reagents, microbial diagnostic reagents, urine diagnostic reagents, coagulation diagnostic reagents, hematology and flow cytometry diagnostic reagents.

The major vitro diagnostics reagents player in the market

• Roche
• Siemens
• Abbott
• Danaher
• Thermo Fisher
• BioMerieux
• Sysmex Corporation
• Ortho Clinical Diagnostics
• BD
• Bio-Rad
• Myriad Genetics
• Hologic
• Carlyle Group
• Maccura
• KHB
• DaAn Gene
• Leadman
• Wondfo Biotech
• Mindray
• COMING Medical

In vitro diagnostic instruments are segmented into clinical chemical analysis instruments, immunochemical analysis instruments, blood analysis instruments and microbiological analysis instruments.

The major In vitro diagnostic instruments player in the market

• Abbott Laboratories
• Danaher
• Roche Diagnostics
• Siemens Healthcare
• Thermo Fisher Scientific
• A&T
• A. Menarini Diagnostics
• Abaxis
• Abcam
• Accriva Diagnostics
• Acon Laboratories
• Affymetrix
• Ahram Biosystem
• ARKRAY
• AsuraGen
• Biocartis
• Bio-Rad Laboratories
• CellaVision
• Cepheid
• Chembio Diagnostic Systems
• Sysmex
• Clarity Diagnostics
• Corgenix
• DiagCor
• Drucker Diagnostics
• Myriad Genetics
• BioMerieux
• Alere
• Wondfo
• Mindray

In addition to the companies listed in the above table, Industrial Scientific, Wantai Biological, RONGSHENG BIOTECH, Fosun Group, Hybribio Biotech, Kingmed Diagnostics manufacture In Vitro Diagnosis (IVD) used in physical examination, chronic disease management and Heavy disease surveillance.

Figure In Vitro Diagnosis (IVD) Products Revenue Market Share by Company in 2018

The scale of the medium and low-end market is larger, but the number of competitors is huge. By 2017, there are more than hundreds of China manufacturers of in vitro diagnostic reagents, most of which are concentrated in the field of in vitro diagnosis.In terms of the global market, multinational brands account for nearly 60% of the market, among which roche, cissm, Siemens, danaher and abbott account for 40% of the total market.

Figure Coronavirus COVID- 19 Global Cases

However, the COVID-19 epidemic has entered the period of COVID-19 in Europe and America, with more than 1.1 million confirmed cases overseas. By 24:00 on April 4, the number of confirmed cases in China had dropped to 1,376, and 1024 asymptomatic infections were still under medical observation.

As of 24 o ‘clock on April 4, 207 countries and regions outside China had confirmed 1,114,684 cases, with 78,584 new cases confirmed, and 61,241 more than 60,000 cases died. The number of confirmed cases and deaths in overseas countries were far higher than that in China. Europe and the United States have been the hardest hit: The United States is the world’s largest country with more than 300,000 confirmed cases, with a total of 312,253 confirmed cases.

Figure: COVID-19 Outbreak Evolution for the Current 10 Most Affected Countries

QY forecast and report on their markets based on a variety of factors, such as production performance of major European and U.S. manufacturers, customer contact, and the significant impact of the COVID-19 on product sales.

Figure Global In Vitro Diagnosis (IVD) Products Market Size 2014-2025 (M USD)

The following players are covered in this report:

• Roche
• Abbott
• Danaher
• Siemens
• Thermo Fisher Scientific
• Sysmex
• Biomerieux
• Ortho Clinical Diagnostics
• Becton Dickinson
• Bio-Rad Laboratories
• Hologic
• Johnson and Johnson
• Qiagen
• Myriad Genetics
• Wondfo
• KHB
• DAAN Gene
• Leadman Biochemistry
• Mindray
• BioSino
• Diasorin
• Illumina
• Industrial Scientific
• Wantai Biological
• RONGSHENG BIOTECH
• Fosun Group
• Hybribio Biotech
• Kingmed Diagnostics
• Edan Instruments
• COMING Medical

In Vitro Diagnosis (IVD) Breakdowby Product Type

• In Vitro Diagnostic Reagents
• In Vitro Diagnostic Instruments
• by Diagnostic Method
• Immunoassays
• Molecular diagnostics involves
• Point-of-care testing (POCT)
• chemistry Diagnosis

In Vitro Diagnosis (IVD) Breakdown Data by Application

• Physical Examination
• Chronic Disease Management
• Heavy Disease Surveillance

If you interested in buy full report, Click @ https://www.qyresearch.com/settlement/pre/54d527d3b666a8fb55bf0132d682041f,0,1,Global-In-Vitro-Diagnosis-IVD-Key-Trends-and-Opportunities-to

Sales Contact:

Rahul Singh – Digital Marketing Director

Contact: +91 7028 920 828

Email: rahul@qyresearch.com

USA Registered Office: QY Research, INC.

17890 Castleton, Suite 218,

City of industry, CA – 91748

USA: +1 626 428 8800

Emails – enquiry@qyresearch.com

Web – www.qyresearch.com

About QY Research

QY Research is a leading global market research and consulting company. Established in 2007 in Beijing, China, QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and custom research to help our clients in providing non-linear revenue models and make them successful. We are globally recognized for our expansive portfolio of services.